Mounjaro Heartburn: How Common, How Long It Lasts
Yes. In the Mounjaro trials, 8% of people on 5 mg had heartburn and indigestion, against 3% on placebo: about 3 times the placebo rate. It is the fifth most common side effect in that table. Smaller, slower meals help most.
- In the Mounjaro label
- Yes, with a rate
- On Mounjaro 5 mg
- 8%
- On placebo
- 3%
- Rank in the label table
- 5 of 7
Mounjaro in brief
Half-life about 5 days: after 5 d, half is gone, and five half-lives (25 d) leave about 3%.
Over 40 weeks in SURPASS-1 for type 2 diabetes, 7.8 kg was lost, compared with 1 kg on placebo.
In US dollars, monthly price points cover list price and self-pay offers, each taken from the maker's price page.
Sources: FDA label (DailyMed), healthsystemtracker.org, pricinginfo.lilly.com.
Mounjaro compared with placebo: how often it appears
Mounjaro heartburn rates by dose group, as reported in the label trials. The placebo group from that same trial serves as the comparison group.
| Medicine and dose | Heartburn and indigestion | Placebo | More than placebo | People in the trials |
|---|---|---|---|---|
| Mounjaro 5 mg | 8% | 3% | +5 points | Adults with type 2 diabetes (label term: dyspepsia) |
| Mounjaro 10 mg | 8% | 3% | +5 points | Adults with type 2 diabetes (label term: dyspepsia) |
| Mounjaro 15 mg | 5% | 3% | +2 points | Adults with type 2 diabetes (label term: dyspepsia) |
From the Mounjaro label (DailyMed).
Heartburn: how Mounjaro compares with other GLP-1s
Each label covers its own trials, run in different groups of people. Treat it as a rough guide.
Pill forms are listed in the table too: Foundayo.
| Medicine | Highest rate in the label | Dose group | Placebo | People in the trials |
|---|---|---|---|---|
| 16% | 9 mg | 4% | Adults with obesity or overweight (weight management) | |
| 10% | 15 mg | 4% | Adults with obesity or overweight (weight management) | |
| 9.6% | all doses | 2.7% | Adults with obesity or overweight (weight management) | |
| 9% | 2.4 mg | 3% | Adults with obesity or overweight (weight management) | |
| 8% | 5 mg | 3% | Adults with type 2 diabetes | |
| 7% | 1.8 mg | 1% | Adults with type 2 diabetes | |
| Byetta | 6% | all doses | 3% | Adults with type 2 diabetes |
| 5.8% | 1.5 mg | 2.3% | Adults with type 2 diabetes | |
| Listed, no rate given | – | – | – | |
| Listed, no rate given | – | – | – |
Sources: Wegovy label (DailyMed), Mounjaro label (DailyMed), Zepbound label (DailyMed), Foundayo label (DailyMed), Trulicity label (DailyMed), Saxenda label (DailyMed), Victoza label (DailyMed), Byetta label (DailyMed).
Source: FDA label (DailyMed).
Why it happens when you take Mounjaro
These medicines slow how fast the stomach empties. Food stays longer, which can cause heartburn and indigestion. This happens most often after large or fatty meals.
Source: health.clevelandclinic.org.
What the Mounjaro label says
On the label, heartburn and indigestion are listed, and the wording below reproduces them exactly:
“15 mg): eructation (0.4%, 3.0%, 2.5%, 3.3%), flatulence (0%, 1.3%, 2.5%, 2.9%), gastroesophageal reflux disease (0.4%, 1.7%, 2.5%, 1.7%), abdominal distension (0.4%, 0.4%, 2.9%, 0.8%).”
Source: FDA label (DailyMed).
What helps, step by step
- For now, leave out spicy and fatty foods.
- Rather than lie down after eating, stay upright.
- Eat smaller meals and stop when you feel full. These medicines make your stomach empty more slowly.
- Eat slowly. Your brain needs time to know you are full.
- Greasy, fatty and sugary foods often set symptoms off, so go easy on them.
- If the symptoms do not ease, tell your prescriber. Your dose increases may be slowed, or another GLP-1 may be suggested.
Before you take anything you get from the drugstore, check it with the GLP-1 interactions checker.
Source: health.clevelandclinic.org.